These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 3012175)
1. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties. Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175 [TBL] [Abstract][Full Text] [Related]
2. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT). Takimoto T; Ogura H; Sato H; Umeda R; Hatano M J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054 [TBL] [Abstract][Full Text] [Related]
3. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma. Takimoto T; Umeda R Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937 [TBL] [Abstract][Full Text] [Related]
4. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor. Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line. Yoshizaki T; Takimoto T; Takeshita H; Tanaka S; Furukawa M; Seiki M; Sato H Laryngoscope; 1994 Jan; 104(1 Pt 1):91-4. PubMed ID: 8295464 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids. Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479 [TBL] [Abstract][Full Text] [Related]
8. Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines. Lin CT; Dee AN; Chen W; Chan WY Lab Invest; 1994 Nov; 71(5):731-6. PubMed ID: 7967524 [TBL] [Abstract][Full Text] [Related]
9. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome. Sato H; Takimoto T; Hatano M; Pagano JS; Raab-Traub N J Gen Virol; 1989 Mar; 70 ( Pt 3)():717-27. PubMed ID: 2543756 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells. Steplewski Z; Koprowski H; Andersson-Anvret M; Klein G J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442 [TBL] [Abstract][Full Text] [Related]
12. Differences in the ability of cells to fuse are mediated by strains of Epstein-Barr virus. Takimoto T; Sato H; Ogura H; Tanaka S; Masuda K; Ishikawa S; Umeda R Laryngoscope; 1989 Oct; 99(10 Pt 1):1075-80. PubMed ID: 2552238 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma. Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466 [TBL] [Abstract][Full Text] [Related]